Objectives: Mild Cognitive Impairment (MCI) case-finding criteria have low specificity in
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OBJECTIVES
The concept of Mild Cognitive Impairment (MCI) is widely used to describe a group at high-risk of dementia with a view to earlier therapeutic intervention. Case detection criteria for MCI were initially based on cases referred to specialist units and demonstrated relatively high levels of predictive validity 1 . However, MCI is not by definition a very disabling condition, so most cases do not consult specialists and present more often in general practice. It is thus best characterized from observations derived from general population studies. A number of cohort studies which have involved clinical verification of MCI cases by neurologists have concluded that many persons considered clinically to be MCI and at high risk of dementia are not identified by the clinic-based algorithms currently used [2] [3] [4] [5] and that furthermore of those that are identified as MCI, the majority do not develop dementia even after 8 years of follow-up. 2, [5] [6] [7] [8] There is thus clearly a need to refine case detection procedures for MCI within the general population setting.
MCI refers fundamentally to a recent decline in cognitive performance which cannot be reliably established by reference to a single neuropsychological examination even when age and education adjusted standardization data are available. Moreover neuropsychological studies associated with measures of hippocampal atrophy, as well as post-mortem observations of neurofibrillary pathology in the medial temporal lobes, suggest that MCI is not a separate diagnostic entity but a state mid-way between normal ageing and dementia 9, 10 requiring the identification of clinical cut-off points rather than the establishment of independent biological markers. The methodology generally used to validate MCI criteria, the prospective estimation of rates of evolution towards dementia, has demonstrated current criteria to have high sensitivity but inserm-00457350, version 1 -17 Feb 2010 3 very poor specificity with inacceptable rates of false positives [5] [6] [7] [8] . The principal problem is thus that small changes in cognitive functioning, while very sensitive indicators of MCI tend to be highly non-specific, giving false positive too high to be currently applicable in intervention studies. Numerous studies have attempted to improve detection rates by modifying the type and number of tests and their cut-off 3, 7 , but there has been little attempt to examine the possible contribution of non-cognitive correlates of MCI as supporting diagnostic criteria.
The present study, based on a large multi-centre prospective population study of brain ageing, aims to combine both retrospective and prospective designs to provide a more clinically meaningful 'gold standard' for MCI caseness, and thus suggest clinical characteristics other than the MCI cognitive criteria likely to increase specificity. In this study 'true' cases of MCI are operationally defined by retrospective examination of individual trajectories as persons with no dementia who will receive within the next four years a diagnosis of dementia by a neurologist.
This group are referred to as Dem-MCI. We examine the clinical characteristics of this group in the years preceding the dementia to establish principal discriminating characteristics, and then compare the performance of the algorithms thus derived with existing case identification procedures. The study focuses on non-cognitive features of MCI which may be used to improve specificity levels.
PARTICIPANTS
Subjects for the present study were recruited randomly from the electoral roles of three French In a sub-sample (the Montpellier cohort) MRI structural imaging was performed on every second subject under 85 years at baseline (717 subjects) using fast multislice double echo T2-weighted 2D axial acquisition, 4 mm thick slices, with 0.4 mm between slice spacing covering the whole brain (30 slices, the upper slice passing through the brain vertex). Fast SPGR 3D T1-weighted axial acquisition, with 2 excitations; 124 slices (1mm thick). White matter lesion volume was estimated using a semi-automatic method 20 . Areas of supratensorial white matter hyperintensity (WMH) were segmented on T2 sequences using MRIcro software. A first layer of region of interest (ROIs) corresponding to WMH was created by a semi-automated technique based on intensity thresholding. A second layer of ROIs was then manually outlined on each slide by gross contouring of all WMH. The intersection of the first and second layer was then manually inspected and automatic total volume of WMH obtained. An experienced reader examined all scans. Another experienced neurologist examined 80 randomly chosen scans to asses inter-rater reliability. Inter-reader and intrareader-intraclass correlations coefficients showed good to excellent agreement (0.79 and 0.95 respectively) . Total WMH was calculated as a function of total brain volume, and as the population distribution is highly skewed, data was divided into quartiles.
Diagnosis of Dementia
A preliminary diagnosis and classification of dementia at each follow-up examination was made by the 3C study local clinical investigators according to DSM-IV criteria 21 and validated by a national panel of neurologists independently of the 3C investigators. The date of onset of dementia was the date of the follow-up interview when dementia was diagnosed. Subjects diagnosed with dementia at baseline were excluded from this analysis. For comparison purposes a diagnosis of MCI according to currently used criteria was also made using the revised inserm-00457350, version 1 -17 Feb 2010
7 algorithm (MCI-R) based on cross-sectional evaluation, which has been proposed by an international consensus group 22 . Given the highly abnormal distribution of test scores 'cognitive dysfunction' is defined as being in the lowest quartile on one of the cognitive tests used, adjusted by age and education rather than by standard deviations. This cut-off was found to have included all the subsequent dementia cases. On the only cognitive test for which log normalization was possible (verbal fluency) this cut-off was observed to correspond to >1 SD below the mean of the cohort.
Statistical analyses
Univariate comparisons were carried out using t-tests and chi-squared where relevant. Backward, stepwise logistic regression was carried out on variables found to be significant on univariate analysis. A correlation matrix was used to check colinearity (r>0.80). Hazard ratios (HRs) for the incidence of dementia were estimated using Cox proportional hazard models adjusted for the covariates age, education level and centre across MCI groups, based on results of the stepwise logistic regression. Interactions between variables were examined on this same cohort in a previous report where we found significant interaction with sex on a large number of variables, justifying our decision to examine risk profiles separately for men and women 23 . We have thus stratified our present analyses by sex. Statistical analyses were carried out with SPSS for Windows NT, version 17.0. Stepwise logistic regression was used to identify principal non-cognitive clinical characteristics taking into account confounding effects from the other variables (Table 2) for men and women independantly. From this analysis it was observed that the significant discriminating clinical characteristics of the Dem-MCI group at baseline are in descending order for men ApoE  4 genotype and stroke, difficulties with IADL and glycemia. For women they are ApoE  4 genotype, depression, use of drugs with anticholinergic properties and low BMI. Table 2 here
RESULTS
Within
Finally, a Cox model stratified by gender and adjusted for age, education and study centre was used to establish hazard ratios for conventional MCI-R criteria alone compared to the same criteria supplemented by factors identified from this study (see Table 3 ) in order to assess the impact on specificity of an additional non-cognitive factor added to current MCI-R criteria.
Specificity for MCI-R criteria alone is 60%, rising to 92% with the addition of ApoE  4 for men and women and to 97% in men with either history of stroke or IADL difficulties and to 93% in women with depressive symptomatology and 95% with anticholinergic drug use. Receiver
Operating Characteristics curves were calculated (Table 3) showing no significant loss of discriminability (area under the curve AUC) with improved specificity.
DISCUSSION
In this study we have chosen to substitute the usual definition of MCI based on cross-sectional statistical criteria for cognitive dysfunction by a pragmatic definition which comes closer to the
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clinical meaning of this concept, that is, non-demented elderly persons in a pre-dementia phase (Dem-MCI). Comparing our Dem-MCI cases at baseline with the remainder of the non-demented population we found, not surprisingly, significant differences on all the cognitive domains tested.
Our principal interest here, however, are the non-cognitive differences which might increase the specificity of currently used algorithms. This population study included a large array of clinical variables allowing us to explore a greater number of risk factors than in most previous population studies. We observe above all that Dem-MCI subjects are characterized by a large number of cerebro and cardio vascular risk factors and additionally high levels of depressive symptomatology, IADL difficulties, anticholinergic drug use and non-use of hormonal replacement therapy in women.
Our observations are in agreement with the findings of the Framingham heart study which has previously documented high rates of cardiovascular risk factors in the years preceding onset of MCI and dementia, related in particular to carotid atherosclerosis and subsequent white matter lesions, silent infarcts and stroke 24 . Based on the Montpellier imaging data, Dem-MCI is also characterized by greater white matter lesion volume as observed elsewhere 25, 26 which in turn has been previously associated with increased levels of circulating beta-amyloid peptide 20 . White matter lesion volume may in fact be a further candidate for algorithm modification but unfortunately we were unable to include it in the final model in this analysis as data was only available for one centre. Furthermore, white matter lesions in the hippocampus and medial temporal areas as opposed to total volume may have been a more sensitive predictor of dementia.
Regional analysis on this data set is currently being undertaken.
As indicated by our previous research, risk factors for MCI to dementia are not the same for men and women 23 suggesting that future research should perhaps construct separate criteria for MCI by sex. This would also have important implications for the planning of intervention programmes. The principal question which we aimed to address in the present report was whether by adding any of these non-cognitive variables to conventionally used MCI-R criteria we might improve their specificity in predicting dementia onset without significantly lowering overall discriminability. Our results show that specificity levels may be improved by including ApoE  4 genotype for both men and women. Including stroke and IADL difficulties in MCI algorithms for men and depression and anticholinergic drug use in women would appear to greatly improve detection rates. It is of particular interest to note that two of the significant precursors for women (depression and anticholinergic drug use) are potentially reversible at the present time. This is not the case for men. With regard to the improvement of current criteria, this analysis strongly suggests that increasing difficulty with IADLs should not be an exclusion criteria for MCI as it has in the past, but on the contrary an inclusion criterion. IADL loss in MCI is likely to be much more subtle than in dementia, probably principally related to difficulties in executive skills and action sequencing rather than psychomotor impairment. We have used loss of one or more IADLs as a criterion based on previous research on frailty in this population 27 . This may have been too low a threshold and may have also included persons with disability due to confounding causes such as stroke or cardiac disorders. There is a clear need to develop specific scales for the detection of IADL change in MCI.
Depressive symptomatology is also clearly a very important co-occurring symptom as has been observed elsewhere 28, 29 and has furthermore been associated with cerebral amyloid and tau The strengths of this study have been the large prospective data set which has been able to take into account almost all the known risk factors for MCI evolution towards dementia. By retrospective identification of MCI cases it has taken a non-orthodox approach which is closer to the clinical reality of MCI (that is, cognitive impairment which does develop into dementia) than has been provided by past studies using statistical criteria. There are, however, a number of limitations to our study. We do not know how many of the persons in our non-MCI group may have developed dementia more than four years later. Observations from the Montpellier data set allow us to estimate that between four and 7 year follow-up a further 2% of Dem-MCI subjects went on to develop dementia. Assuming a similar low rate in other centres it is unlikely that this may have significantly changed our results, although it is possible that slower onset cases may have different risk factors. This point remains to be clarified by future research on this cohort.
Conversely we have made the assumption that subjects with dementia at four year follow-up actually had MCI at base-line. Results from the Framingham cohort suggest cognitive impairment to be present, however, 13 years before dementia onset 30 and a twin study in which only one twin developed dementia showed significant cognitive loss 20 years before diagnosis 11 . The final inserm-00457350, version 1 -17 Feb 2010
13 question is whether we may have achieved similar results by simply changing the cognitive test cut-off point within existing MCI-R criteria. This has already been attempted within case-control studies and prospective cohorts using a wide range of neuropsychological tests 2, 4, 5, 31, 32 with the common finding that prevalence rates vary widely, (10-74% 31 )with small changes to cut-off points with specificity reaching inacceptable levels over 1.5 standard deviations. Together these results have so far suggested that, in the absence of more disease-specific cognitive tests, other criteria will be necessary.
CONCLUSION
Prospective studies may provide a more clinically relevant method of identifying persons with MCI by redefining it as persons without dementia who will develop the disorder within a short time period. From this alternative MCI cohort we have been able to identify a number of genderspecific non-cognitive clinical variables which may increase the specificity of current casefinding procedures. While the limitations of our study and the need for validation in other cohorts would prevent us from recommending an immediate modification of current MCI criteria, the study suggests that that this approach may in the future be useful in informing the revision process.
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